top of page

Epithra 100 mg Injection

SKU Glenmark Pharmaceuticals Ltd
原始價格

$23,69

促銷價格

$18,48

Epithra 100 mg Injection is a powerful anti-cancer treatment designed to combat a variety of malignancies, including breast, stomach, head and neck, liver, blood, lung, and ovarian cancers, as well as malignant lymphomas, pancreatic cancer, sigmoid-rectal carcinoma, and soft-tissue sarcomas. This medication functions by inhibiting the growth and proliferation of cancer cells, thereby slowing the progression of these diseases and offering patients a fighting chance against their condition. While Epithra shows promise in treating numerous cancers, it's essential to note that its safety and efficacy in children have not yet been confirmed, necessitating caution in pediatric cases. As with any cancer therapy, patients should discuss potential side effects and interactions with their healthcare provider to ensure the best possible outcomes. Epithra represents a vital option in the arsenal against cancer, contributing to personalized treatment plans tailored to individual patient needs. When considering Epithra, it's crucial to maintain open communication with your medical team for optimal management of your treatment journey. Always consult your healthcare professional before starting any new medication to assess its suitability for your specific situation.

數量

Active Pharmaceutical Ingredient

Epirubicin 100 mg

Uses

• Epithra 100 mg injection is utilized in the treatment of breast cancer, which can present with various symptoms such as lumps or changes in breast appearance. This medication helps to target cancerous cells, potentially reducing tumor size and managing symptoms. Patients may experience significant improvement in their condition with the use of Epithra 100 mg injection. Regular monitoring during treatment is essential to assess its effectiveness.
• In cases of gastric cancer, Epithra 100 mg injection plays a crucial role in management. Symptoms such as indigestion, stomach pain, and nausea can be distressing for patients. By administering Epithra 100 mg injection, healthcare providers aim to alleviate these symptoms while addressing the underlying cancer. This injection is part of a comprehensive treatment plan that may include other therapies.
• Epithra 100 mg injection is also effective in treating head and neck cancers, where symptoms can include persistent sore throats and difficulty swallowing. The drug works to combat cancerous growths in these sensitive areas, helping to improve the patient's quality of life. With the use of Epithra 100 mg injection, many patients may find relief from bothersome symptoms. Ongoing evaluation is vital to ensure optimal treatment outcomes.
• For those diagnosed with liver cancer, Epithra 100 mg injection serves as an important therapeutic option. Symptoms such as abdominal discomfort and jaundice can significantly impact daily life. By targeting cancer cells, Epithra 100 mg injection can assist in managing these symptoms and improving overall well-being. This treatment is typically part of a broader approach that may include surgery or radiation therapy.

Benefits

Breast cancer: Breast cancer is a type of cancer that begins in the breast tissue. This cancer can start in different parts of the breast, such as the milk ducts, lobules, or connective tissue. Epithra 100 mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is a potent and very toxic medicine, and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated. Stomach cancer: stomach cancer, also known as gastric cancer, is a type of cancer that begins in the cells of the stomach lining. Symptoms may include indigestion, heartburn, stomach pain or discomfort, bloating, nausea or vomiting, loss of appetite, unintentional weight loss, and black or bloody stools. Epithra 100 mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Neck and Head Cancer: Head and neck cancer includes cancer of the mouth, nose, sinuses or throat. Epithra 100 mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is an effective medicine but it has some bothersome side effects. Therefore, you should discuss the risks and benefits with your doctor. Liver cancer: liver cancer, also known as hepatic carcinoma, is a type of cancer that begins in the cells of the liver. Symptoms of hepatic carcinoma may include abdominal pain or discomfort, loss of appetite, weight loss, fatigue, nausea or vomiting, yellowing of the skin or eyes (jaundice), and swelling in the abdomen or legs. Epithra 100 mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Blood cancer: blood cancer is a type of cancer that affects the blood and bone marrow. Symptoms of blood cancer may include fatigue, weakness, fever, night sweats, weight loss, easy bruising or bleeding, frequent infections, and bone pain. Epithra 100 mg Vial kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells.

Lung cancer: Lung cancer is a type of cancer that begins in the lungs. The main cause of lung cancer is cigarette smoking, but exposure to other environmental factors such as air pollution, radon gas, and workplace exposure to certain chemicals and substances can also increase the risk of developing lung cancer. Anti-cancer Drug Epithra kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated. Malignant lymphomas: Malignant lymphomas are a group of cancers that affect the lymphatic system, which is part of the immune system. The lymphatic system includes lymph nodes, the spleen, the thymus, and bone marrow, among other tissues. Epithra Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Ovarian cancer: Ovarian cancer is a type of cancer that begins in the ovaries, which are the female reproductive organs that produce eggs. Symptoms of ovarian cancer may include abdominal swelling or bloating, pelvic pain, difficulty eating or feeling full quickly, frequent urination, and changes in bowel habits. Epirubicin Injection 100 mg kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated. Pancreatic cancer: Pancreatic cancer is a type of cancer that occurs in the pancreas, an organ located behind the stomach that plays a crucial role in digestion and blood sugar regulation. Symptoms of pancreatic cancer may include abdominal pain, jaundice (yellowing of the skin and eyes), weight loss, loss of appetite, nausea, and vomiting. Epithra 100 mg kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Colorectal cancer: Sigmoid-rectal carcinoma, also known as colorectal cancer, is a type of cancer that occurs in the colon or rectum, which are parts of the large intestine. Symptoms of sigmoid-rectal carcinoma may include changes in bowel habits, such as diarrhoea or constipation, rectal bleeding, abdominal pain or cramping, unexplained weight loss, and fatigue. Epithra 100 mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Soft-tissue sarcomas: Soft-tissue sarcomas are a group of cancers that originate in the soft tissues of the body, such as muscle, fat, nerves, tendons, and cartilage. Soft tissue sarcomas can occur anywhere in the body, but they most commonly develop in the limbs, trunk, or abdomen. Epithra 100 mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.

Side Effects

Most adverse effects do not require medical attention and will go away when your body gets used to the medicine. Inform your doctor if any of these symptoms get severe or bother you for a longer period.

Most Common Side Effects

• Hyper Pigmentation in Nail Skin
• Appetite Loss
• Ulcers
• Pain in the Abdomen
• Vomiting
• Nausea
• Flushing
• Hair Loss

Common Side Effects

• Anaemia
• Dehydration
• Cardiac Problems
• Diarrhoea
• Conjunctivitis
• Inflammation
• Amenorrhea
• Lows levels of Blood Count

How To Use

Epithra 100 mg Injection is administered by a doctor or nurse at a hospital or clinical setting. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits, but do not stop taking it unless your doctor tells you to. You should avoid drinking alcohol, as it may increase your risk of liver damage. Do not self-administer this Epithra 100 mg.

Safety Advice

• Alcohol: It is generally not recommended to drink alcohol while taking Epithra 100 mg Vial. It may increase the risk of liver damage. It is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Anti-cancer Drug Epithra is considered safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Epithra 100 mg may not be needed in these patients. Please consult your doctor. Lower doses may be considered in patients with serum creatinine > 5 mg/dL.
• Breastfeeding: It is not known whether Epithra Injection is excreted in human milk. Because many drugs, including other anthracyclines, are excreted in human milk, and because of the potential for serious adverse reactions in nursing infants from epirubicin, lactating women should be advised not to breastfeed during treatment with Epithra 100 mg and for at least 7 days after the last dose.
• Liver: Epithra 100 mg is recommended for use in patients with mild to moderate liver disease. No dose adjustment is needed in such types of patients. In case patients suffer from severe liver disease, the use of this medicine in such types of people is not recommended, It may worsen the patient's condition.
• Pregnancy: Use of Epithra 100 mg Injection may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Epirubicin Injection 100 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Epithra 100 mg Injection has not any effect on the ability to drive or use machinery.

bottom of page